Quantitative Assessment of Steatosis in Liver Tissue Using Controlled Attenuation Parameter

Quantitative Assessment of Steatosis in Liver Tissue Using Controlled Attenuation Parameter

Bibliographic Details
Main Authors:	Cheng-Kun Wu, Tsung-Hui Hu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-09-01
Series:	Journal of Medical Ultrasound
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929644114001325

Similar Items

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
by: Giovanna Ferraioli, et al.
Published: (2017-05-01)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.
by: Dieter Broering, et al.
Published: (2021-01-01)

Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements
by: Ivana Mikolasevic, et al.
Published: (2021-01-01)

The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice
by: Yi-Hao Yen, et al.
Published: (2017-11-01)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
by: Sun Kyung Jeon, et al.
Published: (2021-01-01)

Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease.
by: Kyu Sik Jung, et al.
Published: (2014-01-01)

Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency
by: Adriana Claudia Lopes Carvalho-Furtado, et al.
Published: (2019-06-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
by: Ivana Mikolasevic, et al.
Published: (2021-01-01)

Correction: Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
by: The Staff
Published: (2014-01-01)

Correction: Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease.
Published: (2014-01-01)

Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?
by: Roxana Sirli, et al.
Published: (2021-01-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

Effect of skin–capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease
by: Syunichiro Kimura, et al.
Published: (2021-08-01)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
by: Yu Ogino, et al.
Published: (2021-08-01)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
by: Sumitro Kosasih, et al.
Published: (2018-01-01)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
by: Abd Hamid, N, et al.
Published: (2018)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
by: Abd Hamid, N., et al.
Published: (2018)

Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease
by: Cong xiang Shao, et al.
Published: (2021-08-01)

The Prevalence and Determinants of Hepatic Steatosis Assessed by Controlled Attenuation Parameter in Thai Chronic Hepatitis C Patients
by: A. Sirinawasatien, et al.
Published: (2020-01-01)

Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard
by: Jaeseung Shin, et al.
Published: (2019-04-01)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter.
by: Hye Won Lee, et al.
Published: (2017-01-01)

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.
by: Thomas Karlas, et al.
Published: (2014-01-01)

Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy
by: Karlas , Thomas, et al.
Published: (2014)

Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
by: Katarzyna Kozłowska-Petriczko, et al.
Published: (2021-04-01)

Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis
by: Po-Ke Hsu, et al.
Published: (2021-03-01)

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease
by: Ahmed M. F. Mansour, et al.
Published: (2020-09-01)

Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance
by: Mariana Verdelho Machado
Published: (2017-07-01)

Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B
by: Ana C. Cardoso, et al.
Published: (2015-11-01)

HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice.
by: Yongjun Lee, et al.
Published: (2017-01-01)

P-58 CONCORDANCE BETWEEN ECOGRAPHY AND THE CONTINUOUS ATTENUATION PARAMETER (CAP) BY TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS OF LIVER STEATOSIS
by: Juan Francisco Rozas, et al.
Published: (2021-09-01)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
by: Na Young Lee, et al.
Published: (2021-01-01)

Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
by: Jeong-Ju Yoo, et al.
Published: (2020-11-01)

Automated assessment of steatosis in murine fatty liver.
by: Deepak Sethunath, et al.
Published: (2018-01-01)

MR Assessment of liver and pancreas steatosis in chronic liver diseases
by: João Pedro Ferreira Silva Vieira
Published: (2020)

Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
by: Da Zhou, et al.
Published: (2016-01-01)

Research progress in controlled attenuation parameter for assessment of fatty liver disease
by: LU Jiafa
Published: (2015-05-01)

Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis
by: Hu YB, et al.
Published: (2018-07-01)

TLR4/AP-1-Targeted Anti-Inflammatory Intervention Attenuates Insulin Sensitivity and Liver Steatosis
by: Xiang Hu, et al.
Published: (2020-01-01)

Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.
by: Yi-Hao Yen, et al.
Published: (2017-01-01)